Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anaphylaxis
100%
Dry Powder
100%
EpiPen
100%
Needle-free
100%
Intranasal Epinephrine
100%
Fast-acting
100%
Nasal Allergen Challenge
60%
Analyte Concentration
40%
Autoinjector
40%
Pharmacokinetic/pharmacodynamic (PK/PD)
40%
Area under the Curve
20%
Therapeutic Window
20%
Pharmacokinetics
20%
Allergic Reaction
20%
Coefficient of Variation
20%
Asthma
20%
Shelf Life
20%
Adverse Events
20%
Clinical Benefit
20%
High Cost
20%
Emergency Treatment
20%
Inconvenience
20%
Open-label Trial
20%
Reaction Types
20%
Tmax
20%
Lifesaving
20%
Absorption Phase
20%
Sampling Period
20%
Product Offering
20%
Pocket-sized
20%
Room Temperature Conditions
20%
Challenge Test
20%
Pharmacodynamic Response
20%
Immediate Type
20%
Nasal Powder
20%
Epinephrine Auto-injector
20%
Powder Spraying
20%
Nasal Spray
20%
Seasonal Allergic Rhinitis
20%
Intranasal Absorption
20%
Plasma Analyte
20%
Well Tolerated
20%
Well Treatment
20%
Anaphylaxis Management
20%
Treatment-related Adverse Events
20%
Nursing and Health Professions
Epinephrine
100%
Anaphylaxis
100%
Dry Powder
100%
Epinephrine Autoinjector
100%
Allergen
50%
Pharmacodynamics
50%
Absorption
50%
Adverse Event
33%
Accident Prevention
33%
Asthma
16%
Area under the Curve
16%
Room Temperature
16%
Shelf Life
16%
Provocation Test
16%
Emergency Treatment
16%
Open-Label Trial
16%
Nasal Spray
16%
Pollen Allergy
16%
Therapeutic Window
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epinephrine
100%
Anaphylaxis
100%
Pharmacodynamics
42%
Allergen
42%
Pharmacokinetics
42%
Adverse Event
28%
Therapeutic Window
14%
Asthma
14%
Provocation Test
14%
Open-Label Trial
14%
Pollen Allergy
14%
Nasal Spray
14%